BlinkLab Limited (ASX: BB1) - Share Price

- Current share price for BB1 : $0.675

BlinkLab Limited (BB1), an ASX-listed company,, a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism and ADHD. The Company's most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old.

BB1 General Information ⁺

ASX Code	BB1
Website	http://www.blinklab.org
Industry/Sector	Health Care Technology
Market Cap ($M)	103
BB1 Share Price	$0.675
Day High	$0.710
Day Low	$0.670
Last Close	$0.675
BB1 Share Price Movement	- ( No change )

Prices as at 16:35, 4 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

BlinkLab Limited (BB1) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from BlinkLab Limited (BB1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

BlinkLab Limited (BB1) price-sensitive announcements

BB1 - Trading Halt

BlinkLab Limited (ASX: BB1) requested a trading halt for its securities on 3 August 2026,

BlinkLab Limited (BB1)
3 Aug 2026 | 9:24 AM

BB1 - 2026 Annual Report & Appendix 4E

The 2026 Annual Report & Appendix 4E for BlinkLab Limited outlines the financial performan

BlinkLab Limited (BB1)
31 Jul 2026 | 2:26 PM

BB1 - Quarterly Activities/Appendix 4C Cash Flow Report

BlinkLab Limited has released a Quarterly Activities Report for the quarter ending 30 June

BlinkLab Limited (BB1)
27 Jul 2026 | 9:08 AM

BB1 - Quarterly Activities/Appendix 4C Cash Flow Report

BlinkLab Limited, a leader in digital healthcare, has made significant advancements in its

BlinkLab Limited (BB1)
30 Apr 2026 | 8:39 AM

BlinkLab Limited (BB1) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	Trading Halt	3 Aug 2026 9:24AM	$0.675	$0.675	fallen by 0%
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	Appendix 4G & Corporate Governance Statement	31 Jul 2026 2:28PM	$0.685	$0.675	fallen by 1.46%
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	2026 Annual Report & Appendix 4E	31 Jul 2026 2:26PM	$0.685	$0.675	fallen by 1.46%
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	BlinkLab to Present at TechKnow Invest Roadshow	27 Jul 2026 9:58AM	$0.590	$0.675	risen by 14.41%
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	Quarterly Activities/Appendix 4C Cash Flow Report	27 Jul 2026 9:08AM	$0.590	$0.675	risen by 14.41%
BlinkLab Limited (BB1) ORDINARY FULLY PAID	Health Care	$103	Change of Director's Interest Notice x4	14 Jul 2026 4:22PM	$0.620	$0.675	risen by 8.87%

BB1 Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$5.71	-$5.60	112.60%	0.00%	0.0%
2024A	-$1.75	-$2.60	283.80%	0.00%	0.0%
2023A	-$0.68	-$0.70	38.80%	0.00%	0.0%

BB1 Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
4DMedical Limited (4DX)	$2,177M	0.3304	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
BlinkLab Limited (BB1)	$103M	1.1264	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Pro Medicus Limited (PME)	$16,946M	0.3919	0.2545	0.2962	147.3297	117.4414	90.6049	0.34%	0.43%	0.57%

BB1 Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	9.36	0.00
Market	0.32	12.80	1.13	0.59
Sector	0.69	19.30	1.60	1.77

BB1 Directors

Name	Position	Start Date
Dr Hendrikus Johannes Boele	Chief Executive Officer, Managing Director	17 Dec 2025
Dr Anton Uvarov	Executive Director	2 Apr 2024
Mr Brian Willoughby Leedman	Non-Executive Chairman, Non-Executive Director	15 Dec 2023
Dr Richard Miles Hopkins	Non-Executive Director	18 Jan 2024

BlinkLab Limited (BB1) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
13 Jul 2026	HOPKINS, Richard	Issued	Indirect Shares	52,308	$0.650	$34,000.200
13 Jul 2026	UVAROV, Anton	Issued	Indirect Shares	83,333	$0.650	$54,166.450
13 Jul 2026	LEEDMAN, Brian	Issued	Indirect Shares	83,333	$0.650	$54,166.450

See all changes in directors' interest & trades for BlinkLab Limited (BB1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

BB1 Management

Name	Position
Sebastiaan K.E. Koekkoek	Chief Scientific Officer
Cornelis Pieter Boele	Chief Technology Officer
Christopher (Chris) Bryan Achurch	Company Secretary

BB1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in BlinkLab Limited (BB1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
9,316,667 (7.44%)	Yulia Uvarova
6,783,333 (5.41%)	Cason Holding BV
5,775,000 (4.61%)	Bello Holding BV
5,775,000 (4.61%)	Inacea Holding BV

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us